Low-multiplicity infection of Moloney murine leukemia virus in mouse cells: effect on number of viral DNA copies and virus production in producer cells.
about
Threshold number of provirus copies required per cell for efficient virus production and interference in moloney murine leukemia virus-infected NIH 3T3 cells.Integrated Moloney murine leukemia virus DNA studied by using complementary DNA which does not recognize endogenous related sequencesChromatin conformation of integrated Moloney leukemia virus DNA sequences in tissues of BALB/Mo mice and in virus-infected cell lines.Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations.Efficient and stable expression of recombinant fibronectin polypeptides.Isolation of recombinant DNA clones carrying complete integrated proviruses of Moloney murine leukemia virus.Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeatDe novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells.gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated formsMultiple integration sites for Moloney murine leukemia virus in productively infected mouse fibroblasts.Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic miceAddition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological propertiesGeneration and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesisRearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.Mapping of DNase I-hypersensitive sites in the 5' and 3' long terminal repeats of integrated moloney murine leukemia virus proviral DNAGeneration of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo.Generation of infectious Moloney murine leukemia viruses with deletions in the U3 portion of the long terminal repeatExpression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversionMethylation state and DNase I sensitivity of chromatin containing Moloney murine leukemia virus DNA in exogenously infected mouse cellsFrequent hereditable shutdown of murine retrovirus gene expression in murine cell linesGerm line integration of Moloney leukemia virus: identification of the chromosomal integration site.Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.Integration-specific retrovirus expression in embryonal carcinoma cellsGenetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA.Immortalization of human lymphocytes by fusion with cytoplasts of transformed mouse L cells.
P2860
Q33784885-EAE64B6C-D095-4DA7-B358-C045B0E79EFCQ33916194-FE141FEB-4E7C-404A-90F4-88A1BD50133AQ33919093-03E4E431-69C3-48EB-97AF-16851CBD66F2Q33927247-7A26B2BB-4BDB-4A72-BCAE-0A27566B2316Q34592991-2A00EFB5-4B36-4978-BD2C-C42FC53D8876Q35235278-396721BC-65C1-4CF6-9C11-876ED168E098Q35861652-735CE5CE-61C9-4330-828B-DB5975A7DC85Q36230303-23DFA3E7-D911-4320-9AE3-949655D3042BQ36302181-F079330A-AC5C-4708-9A22-3785F84556BCQ36498177-536B729C-7046-40A3-959C-69DB11D47A68Q36498542-0A6005ED-7D5D-4D11-AD8F-84CE88B36965Q36655037-01176E66-EAB7-40F6-BA2D-06EDFA73C1BDQ36752974-87A9D19F-B5A8-4BF1-BA15-C7DE30FFCC7BQ36812061-8180D936-B27B-44A7-99DB-541F9B5621D8Q36871966-25047DF8-C368-4D97-AB12-52D5016F5BB9Q36883505-9769657C-C893-4210-B88C-8717F9E0C6A7Q36883831-E7515BA3-6B45-4319-83B7-D78534A78CC9Q36886914-2156C68C-7FB1-4E3A-92D7-653600F38F58Q36900374-79BDEB47-D521-486D-96C5-C4A71860D66CQ36902155-F583F6F0-56B3-443A-B2AB-50FEDB4DD02BQ36902384-AFFF0C25-0098-4018-B3A0-1191593A29EEQ36915380-7B5B219C-EB95-40A2-897D-FA3BBF7F7EFDQ36926362-88CCD380-423B-43D3-87AC-AC1AE9559D7BQ36944466-F528F254-7D50-41F6-893A-D0F29055D36DQ37328275-E93102B5-9F22-49F8-84EB-966D665796ACQ37515362-1A668DB5-1AED-4665-95D3-6EBA06BC6E32Q37574821-116EE938-C9A4-4591-8223-E7BD047E131CQ37701269-37209CD6-AD77-42BA-9D67-3A991C4F1151Q40107854-56DDF8CE-3741-4603-BB55-90D5325E9F87Q41509656-6A3D415C-5973-42C4-AEB5-40BBC9A4C706
P2860
Low-multiplicity infection of Moloney murine leukemia virus in mouse cells: effect on number of viral DNA copies and virus production in producer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low-multiplicity infection of ...... production in producer cells.
@en
Low-multiplicity infection of ...... production in producer cells.
@nl
type
label
Low-multiplicity infection of ...... production in producer cells.
@en
Low-multiplicity infection of ...... production in producer cells.
@nl
prefLabel
Low-multiplicity infection of ...... production in producer cells.
@en
Low-multiplicity infection of ...... production in producer cells.
@nl
P2860
P1433
P1476
Low-multiplicity infection of ...... s production in producer cells
@en
P2093
P2860
P304
P407
P577
1978-12-01T00:00:00Z